成都史紀(jì)生物制藥有限公司是集動(dòng)物疫苗研發(fā)、生產(chǎn)、銷售與技術(shù)服務(wù)為一體的國家高新技術(shù)企業(yè)。公司累計(jì)投資超過5億元人民幣，現(xiàn)擁有3個(gè)疫苗生產(chǎn)車間，8條獨(dú)立的活/滅活疫苗生產(chǎn)線，并配套相應(yīng)規(guī)模的質(zhì)量控制實(shí)驗(yàn)室、實(shí)驗(yàn)動(dòng)物房等設(shè)施，年產(chǎn)能達(dá)150億頭(羽)份。

公司擁有獨(dú)特的雙品牌核心競爭力“3-6-5”，即史紀(jì)生物^?3大極致工藝(ICF懸浮培養(yǎng)工藝、ABE純化工藝、HR&IE劑型工藝) ，鑄就6系列苛刻品質(zhì)疫苗產(chǎn)品，慧眼實(shí)驗(yàn)室5項(xiàng)技術(shù)服務(wù)，助力豬業(yè)健康。

Chengdu SG-Biotech Co., Ltd. is a national high-tech enterprise that integrates the research and development, production, sales, and technical services of animal vaccines. The company has accumulated an investment of over 500 million RMB and currently operates three vaccine production workshops with eight independent live/inactivated vaccine production lines. These are complemented by corresponding quality control laboratories, experimental animal facilities, and other facilities, enabling an annual production capacity of 15 billion doses. The company boasts a unique dual-brand core competitive advantage known as "3-6-5," representing the three ultimate processes of  SG-Biotech^? (ICF Suspension Culture Process, ABE Purification Process, HR&IE Formulation Process). This results in the creation of six series of high-quality vaccine products and five technical services from the Huiyan Laboratory, all contributing to the promotion of swine industry health.